Table 3.

Analyses using self-reported CHU9D and tariffs from an adult population

	Self-reported CHU9D Tariffs based on preferences of a youth population		Parent-reported CHU9D Tariffs based on preferences of an adult population
	MMM (n = 197) mean ± se	MAU (n = 199) mean ± se	MMM (n = 197) mean ± se	MAU (n = 199) mean ± se
Baseline	0.642 ± 0.016	0.631 ± 0.016	0.806 ± 0.009	0.802 ± 0.008
End-of-treatment (week 18)	0.728 ± 0.016	0.684 ± 0.018	0.873 ± 0.008	0.844 ± 0.009
Follow-up (week 26)	0.769 ± 0.015	0.708 ± 0.186	0.886 ± 0.008	0.839 ± 0.009
QALY	0.352 ± 0.007	0.335 ± 0.007	0.426 ± 0.003	0.414 ± 0.004
Incremental QALYs
Unadjusted	0.017 ± 0.009		0.012 ± 0.005
Adjusted for baseline	0.014 (95% CI: 0.002–0.027)		0.010 (95% CI: 0.004–0.016)
ICER	€210,757 /QALY gained		€291,916 /QALY gained

Values presented are the mean (standard error (SE)) of the intention-to-treat population from 20 imputed datasets. Adjusted incremental quality adjusted life years (QALY) are adjusted for baseline utility. The confidence intervals (CIs) were derived from 10,000 bootstrap replications from 20 imputed datasets using the standard normal method

CHU9D Child Health Utility 9D, ICER Incremental Cost-Effectiveness Ratio